Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCTX | AZN | AMGN | GILD | BMY |
| Company | Lineage Cell Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.5700 | 189.15 | 346.00 | 131.54 | 58.86 |
| High | 1.5827 | 189.63 | 347.66 | 132.33 | 59.21 |
| Low | 1.5400 | 187.56 | 342.52 | 129.28 | 58.35 |
| Latest | 1.5800 | 188.87 | 345.97 | 130.37 | 58.65 |
| Change | +0.0200 | -3.43 | -2.65 | -3.27 | -0.37 |
| % Change | +1.28% | -1.78% | -0.76% | -2.45% | -0.63% |
| Volume | 464,123 | 1,503,643 | 967,991 | 2,113,899 | 2,775,200 |
| 20-Day Average Volume | 985,105 | 1,884,140 | 2,393,276 | 5,070,975 | 9,307,718 |
| Previous Close | 1.5600 | 192.30 | 348.62 | 133.64 | 59.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5697 | 199.31 | 348.92 | 137.64 | 59.13 |
| 20-Day Raw Stochastic | 38.33% | 6.36% | 41.95% | 4.73% | 28.37% |
| 20-Day Relative Strength | 47.07 | 42.14 | 44.71 | 35.58 | 48.86 |
| Weighted Alpha | +104.07 | +31.41 | +21.49 | +20.93 | +25.85 |
| Today's Opinion | 32% Sell | 48% Buy | 8% Buy | 8% Buy | 48% Buy |
| Previous Opinion | 32% Sell | 64% Buy | 24% Buy | 24% Buy | 48% Buy |
| Last Month's Opinion | 8% Sell | 56% Buy | 56% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.48% since 04/17/26 | -7.81% since 04/17/26 | -2.82% since 04/17/26 | -5.50% since 04/17/26 | -2.54% since 04/17/26 |
| Low | 1.5400 on 04/24/26 | 187.56 on 04/24/26 | 340.06 on 04/21/26 | 129.43 on 04/24/26 | 57.79 on 04/21/26 |
| High | 1.7000 on 04/20/26 | 203.37 on 04/20/26 | 356.90 on 04/20/26 | 138.54 on 04/20/26 | 60.12 on 04/20/26 |
| 1-Month | |||||
| %Chg | +5.74% since 03/24/26 | +1.63% since 03/24/26 | -0.90% since 03/24/26 | -5.82% since 03/24/26 | +2.18% since 03/24/26 |
| Low | 1.4500 on 04/13/26 | 182.79 on 03/26/26 | 335.06 on 04/07/26 | 129.43 on 04/24/26 | 57.22 on 04/15/26 |
| High | 1.7500 on 04/17/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -2.80% since 01/23/26 | +1.57% since 01/23/26 | +0.16% since 01/23/26 | -4.31% since 01/23/26 | +7.30% since 01/23/26 |
| Low | 1.4200 on 03/24/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 129.43 on 04/24/26 | 54.21 on 01/29/26 |
| High | 1.9850 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -7.94% since 10/24/25 | +13.35% since 10/24/25 | +18.35% since 10/24/25 | +7.55% since 10/24/25 | +33.79% since 10/24/25 |
| Low | 1.4200 on 03/24/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 2.0900 on 11/03/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 388,577 | 298,239,616 | 188,144,976 | 165,876,912 | 120,503,200 |
| Shares Outstanding, K | 249,088 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 14,560,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -63,530,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 6,610,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 850,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.79 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/05/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/12/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | 0.080 on 12/15/03 | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.27 | 15.83 | 16.31 | 9.56 |